← Back to headlines
China Approves New Breast Cancer Therapy by Daiichi Sankyo, AstraZeneca
China has given its approval for an innovative breast cancer therapy developed jointly by pharmaceutical companies Daiichi Sankyo and AstraZeneca, expanding treatment options for patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
2h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
9h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
12h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
20h ago